Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for ...
Sartorius Stedim Biotech SA / Key word (s): Dividend Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting 07-Feb-2025 ...
AstraZeneca cuts UK investment after government reduces site expansion support; Viking secures API supply; Jabil acquires ...
Establishes a comprehensive, fully integrated containment solution that seamlessly connects early-phase development through commercial manufacturing.
KRTL’s joint venture with CIQ goes beyond securing a 19.98% stake (9.99% each for KRTL Biotech and KRTL International) in 3451.5 acres of land, equating to 689.9 acres. This land, located in a ...
Exploring sustainable blister packaging from the lens of material selection, quality regulations, machinability, and ...
W hether you're looking to improve and scale your existing business, starting a new venture or expanding into new markets, this comprehensive list of trusted firms, organisations and services will ...
The French pharma also failed to show that its production process can reproducibly manufacture an API to certain quality standards, the regulator said. Sanofi “repeatedly deviated” from the ...
Paul Hudson, CEO of the pharmaceutical firm Sanofi, has an argument for letting AI make top-level decisions in medicine: It has no attachments. Speaking at a panel in Davos on Tuesday, Hudson said ...
The pharma sector anticipates enhanced incentives for domestic API and biosimilar production to reduce import dependency. To truly elevate India’s healthcare ecosystem, three critical areas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback